Xeris Looks Ridiculously Cheap If Growth Forecasts Are Even Halfway Right
Source: SeekingAlpha
2026-05-30 23:31:08 ET
...
Read the full article on Seeking Alpha
For further details see:
Xeris Looks Ridiculously Cheap If Growth Forecasts Are Even Halfway Right
Aquestive Therapeutics Inc.
NASDAQ: AQST
AQST Trading
-3.83% G/L:
$4.015 Last:
585,786 Volume:
$4.14 Open:
AQST Latest News
May 13, 2026 04:01:00 pm
Aquestive Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
May 12, 2026 09:31:25 am
Aquestive Therapeutics Completes $150 Million Debt Refinancing with Oaktree
AQST Stock Data
$477,556,785
111,815,853
0.67%
63
N/A
Pharmaceuticals
Healthcare
US
Warren
